Bio

Mr. Wahal brings nearly two decades of investment banking and strategic finance experience to H2C, advising public and private organizations on valuation, tactics and positioning, buy-side advisory, competitive sell-side processes, negotiated transactions, and more. His capital raising experience includes providing advice to both publicly traded and private organizations related to equity, equity-linked and debt instruments (investment-grade and high-yield) for event-related transactions, and regular course financings. Much of his investment banking career has been devoted to healthcare, with a strong focus on healthcare services, including managed care, health systems, distributors, healthcare IT, and other services providers. Mr. Wahal has advised on transactions with total cumulative value in excess of $150 billion, including Aetna’s acquisition of Coventry Health, Anthem’s acquisition of Simply Healthcare, IBM’s acquisition of Truven, CVS’ acquisition of Aetna (acquisition financing), CD&R’s acquisition of Cardinal Health’s stake in naviHealth, the merger of Thermo Electron and Fisher Scientific, United Healthcare’s acquisition of Sierra Health, and Cardinal Health’s acquisition of Medtronic assets (acquisition financing), along with numerous other engagements of various sizes and structures. Prior to joining H2C, Mr. Wahal led the healthcare business of Corporate Advisory Group at MUFG, engaging with clients to develop long-term relationships and provide acquisition financing in conjunction with strategic advice. He began his investment banking career in 2004 in New York at Citigroup and further developed his expertise and skills in client engagement at Lehman Brothers (acquired by BarCap), Lazard Freres, and UBS Investment Bank. Mr. Wahal earned Bachelor of Science degrees in Finance and Economics with Honors from Barret Honors College and W. P. Carey School of Business at Arizona State University. He also holds a degree in Animal Biology (Zoology).